23
Helping People. Its who we are and what we do. DRAFT Essential Diabetes Drug List Draft Report Date: January 14, 2019 Richard Whitley, MS Director Steve Sisolak Governor Prepared by: Primary Care and Health Workforce Development Office, State of Nevada Division of Public and Behavioral Health (DPBH) 4150 Technology Way, Suite 300 Carson City, NV 89706 Office: (775) 684-4255 Email: [email protected] drugtransparency.nv.gov Julie Kotchevar, PhD DPBH Administrator DRAFT

DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Helping People. It’s who we are and what we do.

DRAFT Essential Diabetes

Drug List

Draft Report Date:

January 14, 2019

Richard Whitley, MS

Director

Steve Sisolak

Governor

Prepared by: Primary Care and Health Workforce Development Office, State of Nevada

Division of Public and Behavioral Health (DPBH) 4150 Technology Way, Suite 300 Carson City, NV 89706

Office: (775) 684-4255 Email: [email protected] drugtransparency.nv.gov

Julie Kotchevar, PhD

DPBH Administrator

DRAFT

Page 2: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

2

Helping People. It’s who we are and what we do.

Introduction

During the 79th legislative session, Senate Bill (SB) 539, which supports prescription drug transparency, was approved. SB 539 was codified in Nevada Revised Statute (NRS) 439B. The law requires in NRS 439B.630 that the Department of Health and Hu-man Services (DHHS) compile a list of prescription drugs essential for treating diabetes in Ne-vada:

NRS 439B.630 Department to annually compile lists of certain prescription drugs essential for treating diabetes. On or before February 1 of each year, the De-partment shall compile:

1. A list of prescription drugs that the Department determines to be essential for treat-ing diabetes in this State and the wholesale acquisition cost of each such drug on the list. The list must include, without limitation, all forms of insulin and biguanides mar-keted for sale in this State.

2. A list of prescription drugs described in subsection 1 that have been subject to an increase in the wholesale acquisition cost of a percentage equal to or greater than:

a.) The percentage increase in the Consumer Price Index, Medical Care Compo-nent during the immediately preceding calendar year; or

b.) Twice the percentage increase in the Consumer Price Index, Medical Care Component during the immediately preceding 2 calendar years.

(Added to NRS by 2017, 4297)

The first essential diabetes drug list was published on October 31, 2017. The list published in this report provides a draft version of the 2019 Essential Diabetes Drug List. The public and other stakeholders can request updates to this draft list by 7PM Pacific Standard Time on Wednesday, January 23, 2019 using the email address [email protected]. All re-quests will be carefully reviewed before updating and posting the final list online by the re-quired deadline of February 1, 2019. This final list will include the price increase data required by NRS 439B.630, Section 2. Manufacturers that produce drugs found on this list are required to submit reports by April 1, 2019 that include information about these drugs as outlined in NRS 439B.635 and NRS 439B.640. Additionally, Pharmacy Benefit Manager (PBMs) are re-quired to provide information to DHHS by April 1, 2019 regarding these drugs as outlined in NRS 439B.645.

Report Methodology

To compile the draft DHHS essential diabetes drug list, DHHS utilized a methodology that met the requirements of NRS 439B.630. Two versions of the list are published: (1) a summary of the nonproprietary and brand or proprietary drug names found on the essential list [Appendix 1], and (2) a detailed list of all the drug National Drug Codes (NDCs) indicated by DHHS as essen-tial diabetes drugs [Appendix 2]. The summary list (Appendix 1) is conveniently formatted for the public and health care providers while the NDC list (Appendix 2) is designed for drug man-ufacturers and PBMs to know which specific drug NDCs will be monitored by DHHS and includ-ed on its yearly report.

DRAFT

Page 3: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

3

Helping People. It’s who we are and what we do.

To generate the list, DHHS identified NDCs that included varying drug packing formula-tions based on prior and current stakeholder input of essential diabetes drugs. These NDC codes were filtered down to include the drugs for which Medicaid expended funds in the past two years. Additional NDCs that were of interest to the public and stakehold-ers were added to this list.

This essential list does not include any drugs used to treat co-morbidities often present in an in-dividual with diabetes. The list does not contain every single drug that may be an effective treat-ment for diabetes or approved for the treatment of diabetes. This list attempts to refine the nu-merous treatments to those approved for treatment, identified by prescribers as essential, and most frequently prescribed in Nevada (as determined by the publicly available data sources). For this reason, some brand names are excluded when generics or alternative brands are includ-ed.

DHHS invites you to view the Drug Transparency website at drugtransparency.nv.gov. If you are interested in receiving email notifications for Nevada Drug Transparency information and up-dates, please subscribe online to the DHHS Drug Transparency LISTSERV.

DRAFT

Page 4: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

4

Helping People. It’s who we are and what we do.

Appendix 1:

2019 Draft DHHS Essential Diabetes

Drugs Summary List

DRAFT

Page 5: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 1: Essential Diabetes Drugs Summary List

Page 1 of 2

Essential Non-Propietary Drug NameIncluded Essential Drug Brand Names

(Note: some brand names are excluded from this list)

Pioglitazone and Metformin HCL Actoplus Met; Actoplus Met XR

Pioglitazone Actos

Lixisenatide Adlyxin

Insulin Lispro

Admelog; Humalog; Humalog 50-50; Humalog 75-25;

Humalog Jr

Insulin Human

Afrezza; Humulin; Humulin N; Humulin R; Humulin R500;

Novolin R; Novolin N; Novolin 70/30

Glimepiride Amaryl

Insulin Glulisine Apidra

Rosiglitazone Avandia

Insulin Glargine Basaglar; Lantus; Toujeo

Exenatide Bydureon; Bydureon BCise; Byetta

Bromocriptine Mesylate Cycloset

Dapagliflozin Farxiga

Insulin Aspart Fiasp; Novolog; Novolog 70/30

Metformin HCL

Fortamet ER; Glumetza ER; Glucophage; Glucophage XR;

Riomet; Metformin ER

Glipizide Glucotrol; Glucotrol XL; Glipizide XL; Glipizide ER

Glyburide Glynase

Miglitol Glyset

Empagliflozin and Linagliptin Glyxambi

Canagliflozin and Metformin HCL Invokamet; Invokamet XR

Canagliflozin Invokana

Sitagliptin and Metformin HCL Janumet; Janumet XR

Sitagliptin Januvia

Empagliflozin Jardiance

Linagliptin and Metformin HCL Jentadueto; Jentadueto XR

Alogliptin and Metformin HCL Kazano

Saxagliptin and Metformin HCL Kombiglyze XR

Insulin Detemir Levemir

Alogliptin Nesina

Saxagliptin Onglyza

Alogliptin and Pioglitazone Oseni

Semaglutide Ozempic

Repaglinide Prandin

Ertugliflozin and Metformin HCL Segluromet

Insulin Glargine and Lixisenatide Soliqua 100/33

Nateglinide Starlix

Ertugliflozin Steglatro

Ertugliflozin and Sitagliptin Steglujan

Pramlintide Acetate SymlinPen

Empagliflozin and Metformin HCL Synjardy; Synjardy XR

Albiglutide Tanzeum

Linagliptin Tradjenta

DRAFT

hmitchell
Rectangle
Page 6: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 1: Essential Diabetes Drugs Summary List

Page 2 of 2

Essential Non-Propietary Drug NameIncluded Essential Drug Brand Names

(Note: some brand names are excluded from this list)

Insulin Degludec Tresiba

Dulaglutide Trulicity

Liraglutide Victoza

Colesevelam HCL Welchol

Dapagliflozin and Metformin HCL Xigduo XR

Insulin Degludec and Liraglutide Xultophy 100/3.6

Acarbose

Glipizide and Metformin HCL

Glyburide and Metformin HCL

Pioglitazone and Glimepiride

DRAFT

hmitchell
Rectangle
Page 7: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

5

Helping People. It’s who we are and what we do.

Appendix 2:

2019 Draft DHHS Essential Diabetes Drug

NDC List

DRAFT

Page 8: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 1 of 16

NDC Essential Diabetes Drug Name

47781-0342-01 Acarbose

00054-0142-25 Acarbose

64380-0760-06 Acarbose

69543-0122-10 Acarbose

23155-0149-01 Acarbose

00115-1152-02 Acarbose

00054-0140-25 Acarbose

64380-0758-06 Acarbose

16252-0523-01 Acarbose

69543-0120-10 Acarbose

47781-0340-01 Acarbose

00054-0141-25 Acarbose

00378-2821-77 Acarbose

47781-0341-01 Acarbose

69543-0121-10 Acarbose

64380-0759-06 Acarbose

64764-0158-60 Actoplus Met

64764-0510-30 Actoplus Met XR

64764-0310-30 Actoplus Met XR

64764-0151-05 Actos

64764-0151-04 Actos

64764-0301-15 Actos

64764-0301-14 Actos

64764-0451-24 Actos

64764-0451-25 Actos

00024-5745-02 Adlyxin

00024-5747-02 Adlyxin

00024-5924-10 Admelog

47918-0891-90 Afrezza

47918-0882-36 Afrezza

47918-0874-90 Afrezza

47918-0902-18 Afrezza

47918-0884-63 Afrezza

47918-0894-63 Afrezza

47918-0880-18 Afrezza

47918-0878-90 Afrezza

45802-0211-72 Alogliptin-Metformin

45802-0169-72 Alogliptin-Metformin

00039-0221-10 Amaryl

00088-2500-33 Apidra

00088-2502-05 Apidra

00173-0861-18 Avandia

00002-7715-01 Basaglar

00002-7715-59 Basaglar

00574-0106-01 Bromocriptine

00781-5325-31 Bromocriptine

DRAFT

hmitchell
Rectangle
Page 9: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 2 of 16

NDC Essential Diabetes Drug Name

00781-5325-01 Bromocriptine

63304-0962-30 Bromocriptine

00574-0106-03 Bromocriptine

00378-2042-01 Bromocriptine

00378-7096-01 Bromocriptine

00378-7096-93 Bromocriptine

60687-0286-21 Bromocriptine

68382-0110-06 Bromocriptine

00310-6530-04 Bydureon

00310-6520-04 Bydureon

00310-6540-04 Bydureon BCise

00310-6524-01 Byetta

00310-6512-01 Byetta

51660-0996-28 Colesevelam

68012-0258-20 Cycloset

00310-6210-30 Farxiga

00003-1428-11 Farxiga

00310-6205-30 Farxiga

00169-3204-15 Fiasp

00169-3201-11 Fiasp

59630-0575-60 Fortamet ER

59630-0574-60 Fortamet ER

55111-0320-05 Glimepiride

55111-0320-01 Glimepiride

68001-0177-00 Glimepiride

54458-0968-10 Glimepiride

61442-0115-01 Glimepiride

16729-0001-16 Glimepiride

16729-0001-01 Glimepiride

69452-0128-20 Glimepiride

00093-7254-01 Glimepiride

69452-0128-30 Glimepiride

69543-0123-50 Glimepiride

69543-0123-10 Glimepiride

61442-0116-01 Glimepiride

54458-0967-16 Glimepiride

00093-7255-01 Glimepiride

55111-0321-01 Glimepiride

55111-0321-05 Glimepiride

00378-4012-01 Glimepiride

54458-0967-10 Glimepiride

69452-0129-20 Glimepiride

69543-0124-10 Glimepiride

16729-0002-01 Glimepiride

16729-0002-16 Glimepiride

69543-0124-50 Glimepiride

DRAFT

hmitchell
Rectangle
Page 10: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 3 of 16

NDC Essential Diabetes Drug Name

68001-0178-00 Glimepiride

68645-0572-90 Glimepiride

61442-0116-05 Glimepiride

68001-0178-03 Glimepiride

69452-0130-30 Glimepiride

61442-0117-05 Glimepiride

55111-0322-01 Glimepiride

69452-0130-20 Glimepiride

61442-0117-01 Glimepiride

68645-0573-90 Glimepiride

69543-0125-10 Glimepiride

55111-0322-05 Glimepiride

68001-0179-03 Glimepiride

51079-0426-20 Glimepiride

00093-7256-01 Glimepiride

00093-7256-52 Glimepiride

68001-0179-00 Glimepiride

00378-4013-01 Glimepiride

16729-0003-01 Glimepiride

16729-0003-16 Glimepiride

54458-0966-10 Glimepiride

69543-0125-50 Glimepiride

54458-0966-16 Glimepiride

60505-0142-02 Glipizide

16729-0140-16 Glipizide

16729-0140-00 Glipizide

00781-1453-10 Glipizide

00781-1453-01 Glipizide

00591-0461-10 Glipizide

60505-0142-04 Glipizide

60505-0142-01 Glipizide

60505-0142-00 Glipizide

00591-0461-01 Glipizide

00378-1110-05 Glipizide

00378-1110-01 Glipizide

51079-0811-20 Glipizide

00591-0461-05 Glipizide

68645-0151-59 Glipizide

00591-0460-05 Glipizide

00781-1452-01 Glipizide

00781-1452-10 Glipizide

68645-0150-54 Glipizide

57664-0398-13 Glipizide

00591-0460-10 Glipizide

16729-0139-16 Glipizide

00591-0460-01 Glipizide

DRAFT

hmitchell
Rectangle
Page 11: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 4 of 16

NDC Essential Diabetes Drug Name

00378-1105-05 Glipizide

00378-1105-01 Glipizide

51079-0810-20 Glipizide

60505-0141-02 Glipizide

60505-0141-01 Glipizide

60505-0141-00 Glipizide

16729-0139-00 Glipizide

10370-0746-05 Glipizide ER

10370-0746-01 Glipizide ER

10370-0191-05 Glipizide ER

10370-0191-01 Glipizide ER

00591-0845-10 Glipizide ER

00591-0845-01 Glipizide ER

00378-0431-01 Glipizide ER

00591-0845-15 Glipizide ER

64980-0281-01 Glipizide ER

64980-0281-05 Glipizide ER

68084-0295-21 Glipizide ER

00378-0340-93 Glipizide ER

64980-0279-03 Glipizide ER

00591-0900-30 Glipizide ER

10370-0745-05 Glipizide ER

00378-0342-01 Glipizide ER

68084-0111-01 Glipizide ER

00591-0844-10 Glipizide ER

10370-0745-01 Glipizide ER

00591-0844-15 Glipizide ER

10370-0190-05 Glipizide ER

10370-0190-01 Glipizide ER

00591-0844-01 Glipizide ER

64980-0280-05 Glipizide ER

64980-0280-01 Glipizide ER

68084-0112-01 Glipizide ER

59762-0542-02 Glipizide XL

59762-0542-01 Glipizide XL

59762-0540-01 Glipizide XL

59762-0541-02 Glipizide XL

59762-0541-01 Glipizide XL

00093-7455-01 Glipizide-Metformin

00093-7456-01 Glipizide-Metformin

23155-0116-01 Glipizide-Metformin

00378-3132-01 Glipizide-Metformin

68382-0185-01 Glipizide-Metformin

00378-3133-01 Glipizide-Metformin

23155-0117-01 Glipizide-Metformin

00093-7457-01 Glipizide-Metformin

DRAFT

hmitchell
Rectangle
Page 12: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 5 of 16

NDC Essential Diabetes Drug Name

68382-0186-01 Glipizide-Metformin

00087-6071-11 Glucophage

00087-6060-05 Glucophage

00087-6064-13 Glucophage XR

00049-4120-66 Glucotrol

00049-4110-66 Glucotrol

00049-0174-02 Glucotrol XL

00049-0178-08 Glucotrol XL

00049-0178-07 Glucotrol XL

00049-0170-01 Glucotrol XL

00049-0174-03 Glucotrol XL

68012-0003-16 Glumetza ER

68012-0002-13 Glumetza ER

52817-0120-10 Glyburide

65862-0028-01 Glyburide

00093-8342-01 Glyburide

00093-9477-53 Glyburide

23155-0056-01 Glyburide

52817-0121-10 Glyburide

68382-0657-01 Glyburide

00093-9433-01 Glyburide

00093-8343-01 Glyburide

00093-8343-05 Glyburide

00093-8343-10 Glyburide

00093-8343-98 Glyburide

23155-0057-01 Glyburide

65862-0029-01 Glyburide

23155-0058-01 Glyburide

52817-0122-00 Glyburide

52817-0122-10 Glyburide

68382-0658-10 Glyburide

00093-8344-01 Glyburide

65862-0030-01 Glyburide

23155-0058-10 Glyburide

00093-9364-05 Glyburide

57237-0022-05 Glyburide

00093-8344-10 Glyburide

00093-9364-01 Glyburide

00093-8344-05 Glyburide

00093-9364-10 Glyburide

65862-0030-99 Glyburide

00093-8344-98 Glyburide

00093-9433-05 Glyburide

51079-0872-20 Glyburide

51079-0873-20 Glyburide

63739-0119-10 Glyburide

DRAFT

hmitchell
Rectangle
Page 13: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 6 of 16

NDC Essential Diabetes Drug Name

00093-8034-01 Glyburide Micro

00143-9919-01 Glyburide Micro

00093-8035-01 Glyburide Micro

00143-9920-01 Glyburide Micro

00093-8036-01 Glyburide Micro

00093-8035-05 Glyburide Micro

00143-9918-01 Glyburide Micro

00143-9920-05 Glyburide Micro

00378-1125-10 Glyburide Micro

00228-2752-11 Glyburide-Metformin

65862-0081-01 Glyburide-Metformin

57237-0024-05 Glyburide-Metformin

68382-0654-05 Glyburide-Metformin

57237-0024-01 Glyburide-Metformin

68382-0655-05 Glyburide-Metformin

00093-5712-05 Glyburide-Metformin

57237-0025-05 Glyburide-Metformin

00228-2753-11 Glyburide-Metformin

57237-0025-01 Glyburide-Metformin

65862-0082-01 Glyburide-Metformin

65862-0082-05 Glyburide-Metformin

57237-0023-01 Glyburid-Metformin

65862-0080-01 Glyburid-Metformin

00009-0341-01 Glynase

00009-5014-01 Glyset

00009-5012-01 Glyset

00009-5013-01 Glyset

54868-4203-00 Glyset

00597-0182-30 Glyxambi

00597-0182-90 Glyxambi

00597-0164-30 Glyxambi

00597-0164-90 Glyxambi

00597-0182-39 Glyxambi

00597-0164-39 Glyxambi

00002-7516-59 Humalog

00002-8799-59 Humalog

00002-8799-01 Humalog

00002-7510-01 Humalog

00002-7510-17 Humalog

00002-7712-01 Humalog

00002-7712-27 Humalog

00002-7714-59 Humalog Jr

00002-8798-01 Humalog 50-50

00002-8798-59 Humalog 50-50

00002-7512-01 Humalog 50-50

00002-8797-59 Humalog 75-25

DRAFT

hmitchell
Rectangle
Page 14: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 7 of 16

NDC Essential Diabetes Drug Name

00002-7511-01 Humalog 75-25

00002-8803-01 Humulin 70/30

00002-8803-59 Humulin 70/30

00002-8715-17 Humulin 70/30

00002-8715-01 Humulin 70/30

00002-8805-59 Humulin N

00002-8315-17 Humulin N

00002-8315-01 Humulin N

00002-8215-01 Humulin R

00002-8215-17 Humulin R

00002-8824-27 Humulin R500

00002-8501-01 Humulin R500

50458-0543-60 Invokamet

50458-0542-60 Invokamet

50458-0541-60 Invokamet

50458-0540-60 Invokamet

50458-0943-01 Invokamet XR

50458-0942-01 Invokamet XR

50458-0941-01 Invokamet XR

50458-0940-01 Invokamet XR

50458-0140-30 Invokana

50458-0140-90 Invokana

50458-0141-30 Invokana

50458-0141-90 Invokana

00006-0577-61 Janumet

00006-0577-82 Janumet

00006-0577-62 Janumet

00006-0575-61 Janumet

00006-0575-62 Janumet

00006-0575-82 Janumet

00006-0081-54 Janumet XR

00006-0081-31 Janumet XR

00006-0081-82 Janumet XR

00006-0080-82 Janumet XR

00006-0080-61 Janumet XR

00006-0080-62 Janumet XR

00006-0078-62 Janumet XR

00006-0078-61 Janumet XR

00006-0277-01 Januvia

00006-0277-02 Januvia

00006-0277-28 Januvia

00006-0277-31 Januvia

00006-0277-54 Januvia

00006-0277-82 Januvia

00006-0221-54 Januvia

00006-0221-28 Januvia

DRAFT

hmitchell
Rectangle
Page 15: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 8 of 16

NDC Essential Diabetes Drug Name

00006-0221-31 Januvia

00006-0112-54 Januvia

00006-0112-28 Januvia

00006-0112-31 Januvia

00006-0277-33 Januvia

00597-0152-30 Jardiance

00597-0152-90 Jardiance

00597-0153-90 Jardiance

00597-0153-30 Jardiance

00597-0152-37 Jardiance

00597-0153-37 Jardiance

00597-0148-60 Jentadueto

00597-0148-18 Jentadueto

00597-0146-60 Jentadueto

00597-0146-18 Jentadueto

00597-0147-60 Jentadueto

00597-0147-18 Jentadueto

00597-0270-73 Jentadueto XR

00597-0275-33 Jentadueto XR

00597-0275-81 Jentadueto XR

00597-0270-94 Jentadueto XR

64764-0337-60 Kazano

64764-0335-60 Kazano

00310-6125-60 Kombiglyze XR

00310-6145-30 Kombiglyze XR

00310-6135-30 Kombiglyze XR

00088-2220-33 Lantus

00088-5021-01 Lantus

00088-2219-05 Lantus

00088-5020-05 Lantus

00169-3687-12 Levemir

00169-6438-10 Levemir

53746-0220-01 Metformin

42806-0315-05 Metformin

65862-0010-05 Metformin

50742-0156-10 Metformin

53746-0220-10 Metformin

53746-0220-05 Metformin

49483-0620-10 Metformin

50742-0156-05 Metformin

68382-0760-10 Metformin

67877-0221-01 Metformin

67877-0221-05 Metformin

67877-0221-10 Metformin

43547-0359-50 Metformin

43547-0359-10 Metformin

DRAFT

hmitchell
Rectangle
Page 16: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 9 of 16

NDC Essential Diabetes Drug Name

65162-0220-50 Metformin

65162-0220-11 Metformin

68645-0545-59 Metformin

68645-0546-59 Metformin

42806-0221-05 Metformin

00093-7214-01 Metformin

68645-0300-59 Metformin

68462-0161-05 Metformin

67877-0563-01 Metformin

00378-7187-05 Metformin

23155-0104-05 Metformin

23155-0104-10 Metformin

65862-0010-99 Metformin

00093-7214-10 Metformin

68382-0760-05 Metformin

65862-0010-01 Metformin

68382-0030-10 Metformin

57664-0474-88 Metformin

57664-0474-58 Metformin

68382-0760-01 Metformin

67877-0563-05 Metformin

67877-0563-10 Metformin

57664-0474-51 Metformin

68382-0030-05 Metformin

68382-0030-01 Metformin

23155-0104-01 Metformin

57664-0474-53 Metformin

65162-0220-10 Metformin

00093-1048-10 Metformin

50742-0154-90 Metformin

50742-0154-10 Metformin

68645-0544-59 Metformin

68382-0758-05 Metformin

68382-0758-10 Metformin

43547-0357-10 Metformin

00093-1048-01 Metformin

50742-0154-05 Metformin

00378-7185-05 Metformin

68645-0539-59 Metformin

67877-0561-01 Metformin

67877-0217-05 Metformin

67877-0561-10 Metformin

67877-0561-05 Metformin

68382-0028-10 Metformin

53746-0218-01 Metformin

65862-0008-01 Metformin

DRAFT

hmitchell
Rectangle
Page 17: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 10 of 16

NDC Essential Diabetes Drug Name

53746-0218-05 Metformin

50742-0154-01 Metformin

65862-0008-05 Metformin

42806-0213-10 Metformin

42806-0213-05 Metformin

00904-6326-61 Metformin

68462-0159-01 Metformin

60505-0190-00 Metformin

68462-0159-05 Metformin

42806-0313-05 Metformin

57664-0397-58 Metformin

57664-0397-53 Metformin

65862-0008-99 Metformin

58657-0640-10 Metformin

68462-0159-10 Metformin

23155-0102-01 Metformin

23155-0102-05 Metformin

23155-0102-10 Metformin

57664-0397-51 Metformin

53746-0218-10 Metformin

43547-0357-50 Metformin

68382-0758-01 Metformin

43547-0357-11 Metformin

43547-0248-50 Metformin

67877-0217-10 Metformin

67877-0562-10 Metformin

49483-0621-10 Metformin

57664-0435-58 Metformin

57664-0435-88 Metformin

67877-0562-05 Metformin

65862-0009-05 Metformin

68382-0759-10 Metformin

68382-0759-05 Metformin

57664-0435-53 Metformin

00378-7186-05 Metformin

68382-0759-01 Metformin

68462-0160-01 Metformin

68645-0547-59 Metformin

23155-0103-01 Metformin

23155-0103-05 Metformin

23155-0103-10 Metformin

65862-0009-01 Metformin

43547-0358-50 Metformin

53746-0219-05 Metformin

50742-0155-10 Metformin

50742-0155-05 Metformin

DRAFT

hmitchell
Rectangle
Page 18: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 11 of 16

NDC Essential Diabetes Drug Name

53746-0219-01 Metformin

50742-0155-01 Metformin

68645-0549-59 Metformin

00093-1049-10 Metformin

53746-0219-10 Metformin

43547-0249-50 Metformin

42806-0314-01 Metformin

57664-0435-51 Metformin

42806-0215-01 Metformin

00591-2412-19 Metformin

68682-0018-90 Metformin

68180-0339-09 Metformin

00378-6002-91 Metformin

68180-0336-07 Metformin

00591-2719-60 Metformin

00093-7267-01 Metformin

68682-0017-10 Metformin

00185-4416-01 Metformin

53746-0178-10 Metformin

00093-7267-10 Metformin

67877-0159-05 Metformin

53746-0178-05 Metformin

53746-0178-90 Metformin

67877-0159-01 Metformin

00781-5503-01 Metformin

62037-0571-01 Metformin

68180-0338-01 Metformin

60505-0260-02 Metformin

60505-0260-01 Metformin

62037-0571-10 Metformin

62756-0142-01 Metformin

62756-0142-02 Metformin

51224-0007-50 Metformin

51224-0007-60 Metformin

67877-0159-10 Metformin

53746-0178-01 Metformin

49483-0623-10 Metformin

49483-0623-50 Metformin

49483-0623-09 Metformin

49483-0623-01 Metformin

62756-0143-01 Metformin

33342-0240-11 Metformin

60505-1329-01 Metformin

49483-0624-01 Metformin

53746-0179-01 Metformin

62037-0577-01 Metformin

DRAFT

hmitchell
Rectangle
Page 19: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 12 of 16

NDC Essential Diabetes Drug Name

00093-7212-01 Metformin

51224-0107-50 Metformin

51224-0107-60 Metformin

51927-3105-00 Metformin

38779-2126-05 Metformin

60687-0143-01 Metformin

29033-0032-06 Metformin ER

00591-2720-60 Metformin ER

68180-0337-07 Metformin ER

00378-6001-91 Metformin ER

57664-0686-88 Miglitol

57664-0684-88 Miglitol

57664-0685-88 Miglitol

55111-0329-90 Nateglinide

00591-3355-01 Nateglinide

49884-0985-01 Nateglinide

68382-0722-16 Nateglinide

49884-0984-01 Nateglinide

68084-0458-21 Nateglinide

55111-0328-90 Nateglinide

68382-0721-16 Nateglinide

00591-3354-01 Nateglinide

68084-0459-21 Nateglinide

64764-0125-30 Nesina

64764-0250-30 Nesina

64764-0625-30 Nesina

00169-1837-11 Novolin 70-30

00169-1834-11 Novolin N

00169-1833-11 Novolin R

00169-3303-12 Novolog

00169-7501-11 Novolog

32849-0500-81 Novolog

00169-6339-10 Novolog

00169-3696-19 Novolog 70/30

00169-3685-12 Novolog 70/30

00310-6100-30 Onglyza

00310-6105-50 Onglyza

00310-6105-30 Onglyza

00310-6105-90 Onglyza

00310-6100-90 Onglyza

64764-0121-03 Oseni

64764-0251-03 Oseni

64764-0253-03 Oseni

00169-4132-12 Ozempic

00169-4136-02 Ozempic

00378-0048-77 Pioglitazone

DRAFT

hmitchell
Rectangle
Page 20: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 13 of 16

NDC Essential Diabetes Drug Name

13668-0140-90 Pioglitazone

13668-0140-30 Pioglitazone

33342-0054-07 Pioglitazone

33342-0054-10 Pioglitazone

33342-0054-15 Pioglitazone

16729-0020-15 Pioglitazone

00378-0048-93 Pioglitazone

16729-0020-10 Pioglitazone

54458-0866-10 Pioglitazone

16729-0020-16 Pioglitazone

00093-7271-98 Pioglitazone

00591-3205-05 Pioglitazone

00093-7271-56 Pioglitazone

00591-3205-30 Pioglitazone

00781-5420-92 Pioglitazone

00781-5420-31 Pioglitazone

00591-3205-19 Pioglitazone

16729-0021-16 Pioglitazone

00378-0228-77 Pioglitazone

16729-0021-15 Pioglitazone

00093-7272-98 Pioglitazone

00093-7272-56 Pioglitazone

00378-0228-93 Pioglitazone

16729-0021-10 Pioglitazone

13668-0119-90 Pioglitazone

13668-0119-05 Pioglitazone

33342-0055-07 Pioglitazone

33342-0055-10 Pioglitazone

54458-0865-10 Pioglitazone

00093-2047-98 Pioglitazone

00591-3206-19 Pioglitazone

33342-0055-15 Pioglitazone

00781-5421-92 Pioglitazone

00781-5421-31 Pioglitazone

00591-3206-30 Pioglitazone

13668-0119-30 Pioglitazone

00093-2046-98 Pioglitazone

16729-0022-15 Pioglitazone

00781-5422-31 Pioglitazone

13668-0120-05 Pioglitazone

13668-0120-30 Pioglitazone

13668-0120-90 Pioglitazone

16729-0022-10 Pioglitazone

00591-3207-30 Pioglitazone

00093-7273-56 Pioglitazone

00591-3207-05 Pioglitazone

DRAFT

hmitchell
Rectangle
Page 21: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 14 of 16

NDC Essential Diabetes Drug Name

00781-5422-92 Pioglitazone

16729-0022-16 Pioglitazone

00378-0318-93 Pioglitazone

33342-0056-07 Pioglitazone

33342-0056-10 Pioglitazone

54458-0864-10 Pioglitazone

63304-0313-30 Pioglitazone

00093-7273-98 Pioglitazone

00591-3207-19 Pioglitazone

51079-0513-20 Pioglitazone

68084-0878-01 Pioglitazone

66993-0821-30 Pioglitazone-Glimepiride

00781-5634-31 Pioglitazone-Glimepiride

66993-0822-30 Pioglitazone-Glimepiride

00781-5635-31 Pioglitazone-Glimepiride

13668-0280-60 Pioglitazone-Metformin

65862-0525-60 Pioglitazone-Metformin

00781-5626-60 Pioglitazone-Metformin

00093-7677-06 Pioglitazone-Metformin

00378-1550-91 Pioglitazone-Metformin

13668-0281-60 Pioglitazone-Metformin

57237-0218-60 Pioglitazone-Metformin

00093-7678-06 Pioglitazone-Metformin

65862-0526-18 Pioglitazone-Metformin

65862-0526-60 Pioglitazone-Metformin

33342-0177-09 Pioglitazone-Metformin

00378-1575-91 Pioglitazone-Metformin

00781-5627-60 Pioglitazone-Metformin

60846-0884-01 Prandin

60846-0882-01 Prandin

00169-1837-02 Novolin 70-30

00169-1834-02 Novolin N

00169-1833-02 Novolin R

10631-0206-01 Riomet

10631-0206-02 Riomet

10631-0238-01 Riomet

10631-0238-02 Riomet

00006-5373-03 Segluromet

00006-5373-06 Segluromet

00006-5369-03 Segluromet

00006-5369-06 Segluromet

00006-5374-03 Segluromet

00006-5374-06 Segluromet

00006-5370-03 Segluromet

00006-5370-06 Segluromet

00024-5761-05 Soliqua 100/33

DRAFT

hmitchell
Rectangle
Page 22: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 15 of 16

NDC Essential Diabetes Drug Name

00078-0352-05 Starlix

00078-0351-05 Starlix

00006-5364-03 Steglatro

00006-5364-06 Steglatro

00006-5368-03 Steglujan

00006-5368-06 Steglujan

00006-5367-03 Steglujan

00006-5367-06 Steglujan

00310-6627-02 Symlinpen

00310-6615-02 Symlinpen

00597-0168-18 Synjardy

00597-0168-60 Synjardy

00597-0180-60 Synjardy

00597-0180-18 Synjardy

00597-0175-60 Synjardy

00597-0175-18 Synjardy

00597-0159-18 Synjardy

00597-0159-60 Synjardy

00597-0280-90 Synjardy

00597-0290-74 Synjardy

00597-0280-73 Synjardy XR

00597-0300-93 Synjardy XR

00597-0300-45 Synjardy XR

00597-0295-88 Synjardy XR

00597-0295-78 Synjardy XR

00597-0290-59 Synjardy XR

00173-0866-01 Tanzeum

00173-0866-35 Tanzeum

00173-0867-35 Tanzeum

00024-5871-02 Toujeo

00024-5869-03 Toujeo

00597-0140-61 Tradjenta

00597-0140-30 Tradjenta

00597-0140-90 Tradjenta

00169-2660-15 Tresiba

00169-2550-13 Tresiba

00002-1433-01 Trulicity

00002-1433-80 Trulicity

00002-1434-01 Trulicity

00002-1434-80 Trulicity

00169-4060-12 Victoza

00169-4060-13 Victoza

65597-0902-30 Welchol

65597-0701-18 Welchol

00310-6280-30 Xigduo XR

00310-6270-30 Xigduo XR

DRAFT

hmitchell
Rectangle
Page 23: DRAFT Essential Diabetes Drug List - DHHS homedhhs.nv.gov/uploadedFiles/dhhsnvgov/content/HCPWD/01.14...2019/01/14  · Component during the immediately preceding 2 calendar years

Appendix 2: Essential Diabetes Drugs NDC List

Page 16 of 16

NDC Essential Diabetes Drug Name

00310-6260-60 Xigduo XR

00310-6250-30 Xigduo XR

00169-2911-15 Xultophy 100/3.6

DRAFT

hmitchell
Rectangle